MedTrace Logo

"Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients

NCT00475280 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2022-10-12

No results posted yet for this study

Summary

This study aims at considering clinical heterogeneity of patients based on a "geriatric assessment" without taking into account the real age of the subject. This will allow physicians to adapt therapy according to three different groups of patients: frail, fit and intermediate and to evaluate the efficacy and feasibility of a therapy adapted to the different categories of patients.

Conditions

  • Leukemia, Lymphoblastic, Acute

Interventions

PROCEDURE

Geriatric assessment adapted therapy

Geriatric assessment is performed before the induction phase starts.

PROCEDURE

Stem cells autotransplantation

Stem cells autotransplantation is performed after consolidation treatment

Sponsors & Collaborators

  • Gruppo Italiano Malattie EMatologiche dell'Adulto

    lead OTHER

Principal Investigators

  • Felicetto FERRARA, Dr. · Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli" di Napoli

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2016-12-31
Completion
2020-01-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00475280 on ClinicalTrials.gov